Objective: This study was to investigate whether resistin induces the expression of chemokine ligand 4 (CCL4) during Intervertebral disc degeneration (IVDD) and whether toll-like receptor-4 (TLR-4) and the nuclear factor-κB (NF-κB) signaling pathway are involved in this process.
Methods: The expression pattern of resistin and CCL4 in different degenerated human nucleus pulposus (NP) tissues were measured by quantitative reverse transcription-polymerase chain reaction (qPCR); Effect of resistin on the migration of macrophages was measured by cell migration assay. Resistin-induced CCL4 expression were analyzed by qPCR, Enzyme-linked immunosorbant assay (ELISA) and cell immunofluorescence. Involvement of TLR-4, p38-mitogen-activated protein kinase (p38-MAPK), and NF-κB signaling pathways were studied by small interfering RNA (siRNA) or Lenti-virus mediated knockdown, co-immunoprecipitation, and chromatin immunoprecipitation (ChIP) assay.
Results: Expression of resistin and CCL4 was elevated in degenerated NP tissue. Resistin promoted macrophage migration through CCL4 and its receptor. Expression of CCL4 was significantly increased by resistin treatment. The pharmacological inhibition or siRNA knockdown of TLR-4 blocked the resistin-induced CCL4 expression. Co-immunoprecipitation data confirmed the binding of resistin to TLR4. Pharmacological inhibition of the NF-κB and p38-MAPK signaling pathways attenuated the resistin-induced CCL4 expression. A ChIP assay and lentivirus mediated knockdown showed that resistin regulate CCL4 expression through p65.
Conclusion: This study shows that resistin binds to TLR4 and increase the expression of CCL4 through p38-MAPK and NF-κB signaling pathways in NP cells, and this expression causes infiltration of macrophages. This study might provide a feasible therapeutic target for controlling the inflammatory response associated with IVDD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.joca.2016.10.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of Immune Infiltration-Associated CC Motif Chemokine Ligands as Biomarkers and Targets for Colorectal Cancer Prevention and Immunotherapy.
Int J Mol Sci
January 2025
Centre of Biomedical Systems and Informatics, ZJU-UoE Institute, School of Medicine, International Campus, Zhejiang University, Haining 314400, China.
Colorectal cancer (CRC) is the third most common cancer globally, with limited effective biomarkers and sensitive therapeutic targets. An increasing number of studies have highlighted the critical role of tumor microenvironment (TME) imbalances, particularly immune escape due to impaired chemokine-mediated trafficking, in tumorigenesis and progression. Notably, CC chemokines (CCLs) have been shown to either promote or inhibit angiogenesis, metastasis, and immune responses in tumors, thereby influencing cancer development and patient outcomes.
View Article and Find Full Text PDFQizhu Rougan Granules suppress liver fibrosis by inhibiting the expression of the P2Y14 receptor on hepatic stellate cells.
Front Pharmacol
January 2025
Hospital of Chengdu University of Traditional Chinese Medicine, TCM Hospital of Sichuan Province, Chengdu, Sichuan, China.
Introduction: Liver fibrosis is a globally prevalent chronic liver disease, often representing the advanced stage of various chronic liver conditions. Despite its widespread occurrence, there is currently no widely accepted or effective treatment for liver fibrosis. However, increasing evidence supports the efficacy of Traditional Chinese Medicine (TCM) in inhibiting the progression of fibrosis.
View Article and Find Full Text PDFComparison of immune responses to respiratory syncytial virus in infancy, childhood, and adulthood using an in vitro model of human respiratory infection.
Immunohorizons
January 2025
Section of Infectious Diseases and Epidemiology, Department of Pediatrics, University of Colorado, Aurora, CO, United States.
Respiratory syncytial virus (RSV) is a major contributor to morbidity and mortality in infants. We developed an in vitro model of human respiratory infection to study cellular immune responses to RSV in infants, children, and adults. The model includes human lung epithelial A549 cells or human fetal lung fibroblasts infected with a clinical strain of RSV at a multiplicity of infection of 0.
View Article and Find Full Text PDFChlorogenic Acid Ameliorates CCl4-induced Liver Fibrosis by Modulating the PI3K/AKT/mTOR Autophagy Pathway.
Anticancer Agents Med Chem
January 2025
Department of Basic Medical Sciences, Vision Colleges, Riyadh, 11451, Saudi Arabia.
Background: Liver fibrosis represents a serious risk to global health by impairing quality of life and elevating the chances of hepatocellular carcinoma, while the intricate role of autophagy can either alleviate or worsen fibrosis depending on its functioning.
Objective: Herein, we aimed to investigate the therapeutic effect of chlorogenic acid in CCl4-induced hepatic fibrosis and explore the autophagy pathway as the possible molecular target of chlorogenic acid.
Methods: Rats were injected with carbon tetrachloride (1ml/kg) to induce liver fibrosis for 10 weeks.
MAP17 is a Novel NASH Progression Biomarker Associated with Macrophage Infiltration, Immunotherapy Response, and Oxidative Stress.
J Inflamm Res
January 2025
Department of General Surgery (Hepatopancreatobiliary Surgery), The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, People's Republic of China.
Background: Nonalcoholic steatohepatitis (NASH) has recently garnered increased attention due to immune infiltration. However, the role of membrane-associated protein 17 (MAP17) in NASH remains unclear, which prompted this study to explore its relationship with immune infiltration and its regulatory mechanisms.
Methods: We employed weighted correlation network analysis (WGCNA) to construct a gene co-expression network aimed at identifying key genes associated with NASH progression.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!